1
Arsenic Trioxide With Cyclophosphamide in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Condition(s):Acute Myeloid Leukemia; Relapsed/Refractory Acute Myeloid LeukemiaLast Updated:April 30, 2021Completed
Cyclophosphamide: 4826 Clinical Trials, Page 1 of 483
Hide Studies Not Open or Pending
2
Cyclophosphamide Versus Mycophenolate Mofetil in Lupus Nephritis
Condition(s):To Compare the Effects of Mycophenolate Mofetil With Cyclophosphamide in Neplaese Lupus Nephritis PatientsLast Updated:June 28, 2017Completed
3
Cyclophosphamide in the Treatment of Associated Acquired Lipodystrophy Syndrome With Type 1 Diabetes
Condition(s):Lipodystrophy Acquired; Type1diabetesLast Updated:August 1, 2023Recruiting
4
Cyclophosphamide for Nasopharyngeal Carcinoma
Condition(s):Recurrent Nasopharyngeal Undifferentiated Carcinoma; Stage IV Nasopharyngeal Undifferentiated CarcinomaLast Updated:October 2, 2019Completed
5
Phase 1 Dose-escalating Study of MM-398 (Irinotecan Sucrosofate Liposome Injection) Plus Intravenous Cyclophosphamide in Recurrent or Refractory Pediatric Solid Tumors
Condition(s):Recurrent or Refractory Solid Tumors; Ewing Sarcoma; Rhabdomyosarcoma; Neuroblastoma; OsteosarcomaLast Updated:March 31, 2022Recruiting
6
Cyclophosphamide and Alemtuzumab In Lymphoma
Condition(s):Non Hodgkin Lymphoma; High-grade B-cell Lymphoma; Diffuse Large B Cell LymphomaLast Updated:January 14, 2019Terminated
7
Cyclophosphamide in the Treatment of Refractory Proliferative Arachnoiditis in CNS Tuberculosis
Condition(s):Tuberculosis; Tubercular Meningitis; Arachnoiditis; Tuberculous (Etiology)Last Updated:December 30, 2020Not yet recruiting
8
Sirolimus and Cyclophosphamide in Metastatic or Unresectable Myxoid Liposarcoma and Chondrosarcoma
Condition(s):Conventional Chondrosarcoma; Myxoid Liposarcoma; Mesenchymal Chondrosarcoma; Dedifferentiated ChondrosarcomaLast Updated:April 20, 2022Completed
9
Cyclophosphamide as Graft-versus-host Prophylaxis After Allogeneic Stem Cell Transplantation for Multiple Myeloma
Condition(s):Multiple MyelomaLast Updated:August 23, 2021Active, not recruiting
10
High-dose Cyclophosphamide for Severe Refractory Crohn Disease
Condition(s):Crohn’s Disease; Crohn DiseaseLast Updated:August 13, 2018Withdrawn